"Memorial Hospital at Gulfport is a not-for-profit medical complex in Gulfport, Mississippi, jointly owned by the City of Gulfport and Harrison County. Memorial's mission is Building a Healthier Community. Memorial is one of the most comprehensive healthcare systems in the state, licensed for 328 beds, including a state-designated Level II Trauma Center, three nursing centers, three outpatient surgery centers, satellite outpatient diagnostic and rehabilitation centers and more than 95 Memorial Physician Clinics."

During the past decade, Gulfport Memorial Hospital conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 14 clinical trials were completed, i.e. on average, 60.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 7 clinical trials were completed. i.e. 233.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gulfport Memorial Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 16 trials, followed by "SWOG Cancer Research Network" with 6 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored and "NRG Oncology" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gulfport Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Daiichi Sankyo, Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Gulfport Memorial Hospital" are "Breast Adenocarcinoma" (2 trials), "Breast Ductal Carcinoma In Situ" (2 trials), "Colorectal Cancer" (2 trials), "Coronary Artery Disease" (2 trials) and "HER2/Neu Negative" (2 trials). Many other conditions were trialed in "Gulfport Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Gulfport Memorial Hospital" are "Drug" (24 trials), "Other" (20 trials), "Biological" (16 trials), "Procedure" (9 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (10 trials), "Laboratory Biomarker Analysis" (8 trials), "Biospecimen Collection" (6 trials), "Paclitaxel" (6 trials) and "Cisplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Gulfport Memorial Hospital" are 31 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Gulfport Memorial Hospital". undefined are not yet recruiting, 9 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Gulfport Memorial Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Gulfport Memorial Hospital, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".